Cotylenin a inhibits cell proliferation and induces apoptosis and PAX6 mRNA transcripts in retinoblastoma cell lines

Molecular Vision

Volumn 16, Issue , 2010, Pages 970-982

  Kashiwagi, Yoshiko ^a   Kato, Nobuo ^b   Sassa, Takeshi ^c   Nishitsuka, Koichi ^a   Yamamoto, Teiko ^a   Takamura, Hiroshi ^a   Yamashita, Hidetoshi ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE; COTYLENIN A; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MESSENGER RNA; MYC PROTEIN; RHODOPSIN; TRANSCRIPTION FACTOR PAX6; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINOBLASTOMA; TRANSCRIPTION INITIATION;

APOPTOSIS; CASPASES; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; DITERPENES; DOWN-REGULATION; EXONS; EYE PROTEINS; GENE EXPRESSION; HISTONE DEACETYLASE INHIBITORS; HOMEODOMAIN PROTEINS; HUMANS; PAIRED BOX TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RETINOBLASTOMA; RHODOPSIN; RNA, MESSENGER; UP-REGULATION;

EID: 77955598312     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Albert DM. Historic review of retinoblastoma. Ophthalmology 1987; 94:654-62.
2. Lueder GT, Smith ME. Retinoblastoma. Semin Diagn Pathol 1994; 11:104-6.
3. Nork TM, Schwartz TL, Doshi HM, Millecchia LL. Retinoblastoma: cell of origin. Arch Ophthalmol 1995; 113:791-802.
4. Dyer MA, Bremner R. The search for the retinoblastoma cell of origin. Nat Rev Cancer 2005; 5:91-101.
5. Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, Leal-Leal C, Sharma T, Barnoya M, Epelman S, Pizzarello L, Kane JR, Barfield R, Merchant TE, Robison LL, Murphree AL, Chevez-Barrios P, Dyer MA, O'Brien J, Ribeiro RC, Hungerford J, Helveston EM, Haik BG, Wilimas J. Retinoblastoma: one world, one vision. Pediatrics 2008; 122:e763-70.
6. Sassa T, Tojyo T, Munakata K. Isolation of a new plant growth substance with cytokinin-like activity. Nature 1970; 227:379.
7. Sassa T, Togashi M, Kitaguchi T. The structures of cotylenins A, B, C, D, and E. Agric Biol Chem 1975; 39:1735-44.
8. Sassa T, Ooi T, Nukina M, Ikeda M, Kato N. Structural confirmation of cotylenin A, a novel fusicoccane-diterpene glycoside with potent plant growth-regulating activity from Cladosporium fungus sp. 501-07W. Biosci Biotechnol Biochem 1998; 62:1815-8.
9. Asahi K, Honma Y, Hazeki K, Sassa T, Kubohara Y, Sakurai A, Takahashi N, Cotylenin A. a plant-growth regulator, induces differentiation in murine and human myeloid leukemia cells. Biochem Biophys Res Commun 1997; 238:758-63.
10. Honma Y, Cotylenin A. a plant growth regulator as a differentiation-inducing agent against myeloid leukemia. Leuk Lymphoma 2002; 43:1169-78.
11. Yamamoto-Yamaguchi Y, Yamada K, Ishii Y, Asahi KI, Tomoyasu S, Honma Y. Induction of the monocytic differentiation of myeloid leukaemia cell by cotylenin A, a plant growth regulator. Br J Haematol 2001; 112:697-705.
12. Matsunawa M, Ishii Y, Kasukabe T, Tomoyasu S, Ota H, Honma Y. Cotylenin A-induced differentiation is independent of the transforming growth factor-beta signaling system in human myeloid leukemia HL-60 cells. Leuk Lymphoma 2006; 47:733-40.
13. Honma Y, Ishii Y, Yamamoto-Yamaguchi Y, Sassa T, Asahi K, Cotylenin A. a differentiation-inducing agent, and IFNalpha cooperatively induce apoptosis and have an antitumor effect on human non-small cell lung carcinoma cells in nude mice. Cancer Res 2003; 63:3659-66.
14. Honma Y, Kasukabe T, Yamori T, Kato K, Sassa T. Antitumor effect of cotylenin A plus interferon-alpha: possible therapeutic agents against ovary carcinoma. Gynecol Oncol 2005; 99:680-8.
15. Kasukabe T, Okabe-Kado J, Kato N, Sassa T, Honma Y. Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts. Breast Cancer Res 2005; 7:R1097-110.
16. Honma Y, Akimoto M. Therapeutic strategy using phenotypic modulation of cancer cells by differentiation-inducing agents. Cancer Sci 2007; 98:1643-51.
17. Asahi K, Honma Y, Hazeki K, Sassa T, Kubohara Y, Sakurai A, Takahashi N, Cotylenin A. a plant-growth regulator, induces the differentiation in murine and human myeloid leukemia cells. Biochem Biophys Res Commun 1997; 238:758-63.
18. Reid TW, Albert DM, Rabson AS, Russell P, Craft J, Chu EW, Tralka TS, Wilcox JL. Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 1974; 53:347-60.
19. McFall RC, Sery TW, Makadon M. Characterization of a new continuous cell line derived from a human retinoblastoma. Cancer Res 1977; 37:1003-10.
20. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VX. Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995; 81:801-9.
21. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376:37-43.
22. Arends MJ, Morris RG, Wyllie AH. Apoptosis. The role of the endonuclease. Am J Pathol 1990; 136:593-608.
23. Squire J, Goddard AD, Canton M, Becker A, Phillips RA, Gallie BL. Tumour induction by the retinoblastoma mutation is independent of N-myc expression. Nature 1986; 322:555-7.
24. Murakami T, Ohmori H, Gotoh S, Tsuda T, Ohya R, Akiya S, Higashi K. Down modulation of N-myc, heat-shock protein 70, and nucleolin during the differentiation of human neuroblastoma cells. J Biochem 1991; 110:146-50.
25. Murakami T, Takahashi H, Akiya S, Higashi K. Effects of dibutyryl cyclic AMP on the gene expression during the differentiation of retinoblastoma cells (Y 79) in culture. Nippon Ganka Gakkai Zasshi 1993; 97:703-7.
26. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75:805-16.
27. Shimoda Y, Tajima Y, Osanai T, Katsume A, Kohara M, Kudo T, Narimatsu H, Takashima N, Ishii Y, Nakamura S, Osumi N, Sanai Y. Pax6 controls the expression of Lewis x epitope in the embryonic forebrain by regulating alpha 1,3-fucosyltransferase IX expression. J Biol Chem 2002; 277:2033-9.
28. Foster KW, Saranak J, Patel N, Zarilli G, Okabe M, Kline T, Nakanishi K. A rhodopsin is the functional photoreceptor for phototaxis in the unicellular eukaryote Chlamydomonas. Nature 1984; 311:756-9.
29. Haubst N, Berger J, Radjendirane V, Graw J, Favor J, Saunders GF, Stoykova A, Götz M. Molecular dissection of Pax6 function: the specific roles of the paired domain and homeodomain in brain development. Development 2004; 131:6131-40.
30. Kammandel B, Chowdhury K, Stoykova A, Aparicio S, Brenner S, Gruss P. Distinct cis-essential modules direct the time-space pattern of the Pax6 gene activity. Dev Biol 1999; 205:79-97.
31. Kim J, Lauderdale JD. Analysis of Pax6 expression using a BAC transgene reveals the presence of a paired-less isoform of Pax6 in the eye and olfactory bulb. Dev Biol 2006; 292:486-505.
32. Botrugno OA, Santoro F, Minucci S. Histone deacetylase inhibitors as a new weapon in the arsenal of differentiation therapies of cancer. Cancer Lett 2008; 280:134-44.
33. Karasawa Y, Okisaka S. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells. Jpn J Ophthalmol 2004; 48:542-51.
34. Tsokos M, Kyritsis AP, Chader GJ, Triche TJ. Differentiation of human retinoblastoma in vitro into cell types with characteristics observed in embryonal or mature retina. Am J Pathol 1986; 123:542-52.
35. Kasukabe T, Okabe-Kado J, Honma Y, Cotylenin A. a new differentiation inducer, and rapamycin cooperatively inhibit growth of cancer cells through induction of cyclin G2. Cancer Sci 2008; 99:1693-8.
36. Li A, Zhu X, Brown B, Craft CM. Gene expression networks underlying retinoic acid-induced differentiation of human retinoblastoma cells. Invest Ophthalmol Vis Sci 2003; 44:996-1007.
37. Kim J, Lauderdale JD. Overexpression of pairedless Pax6 in the retina disrupts corneal development and affects lens cell survival. Dev Biol 2008; 313:434-54.
38. Xu S, Sunderland ME, Coles BL, Kam A, Holowacz T, Ashery-Padan R, Marquardt T, McInnes RR, van der Kooy D. The proliferation and expansion of retinal stem cells require functional Pax6. Dev Biol 2007; 304:713-21.
39. Sheng G, Thouvenot E, Schmucker D, Wilson DS, Desplan C. Direct regulation of rhodopsin 1 by Pax-6/eyeless in Drosophila: evidence for a conserved function in photoreceptors. Genes Dev 1997; 11:1122-31.
40. Ikeda H, Osakada F, Watanabe K, Mizuseki K, Haraguchi T, Miyoshi H, Kamiya D, Honda Y, Sasai N, Yoshimura N, Takahashi M, Sasai Y. Generation of Rx+/Pax6+ neural retinal precursors from embryonic stem cells. Proc Natl Acad Sci USA 2005; 102:11331-6.
41. Wiechmann AF. Recoverin in cultured human retinoblastoma cells: enhanced expression during morphological differentiation. J Neurochem 1996; 67:105-10.
42. Yamada K, Honma Y, Asahi KI, Sassa T, Hino KI, Tomoyasu S. Differentiation of human acute myeloid leukaemia cells in primary culture in response to cotylenin A, a plant growth regulator. Br J Haematol 2001; 114:814-21.